← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2014Last known activity
Dec 7, 2021
Acquired by Novo Nordisk on Nov 18, 2021
Timeline
2000s
- Jun 1, 2007
Dicerna Pharmaceuticals, Inc.— Founded
2020s
- Nov 18, 2021
Novo Nordisk— Acquired By
Drugs by trial phase (6 distinct, 14 trials)
Indications
Studied for
- alpha 1-Antitrypsin Deficiency
- Carcinoma
- Carcinoma, Hepatocellular
- Genetic Diseases, Inborn
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hyperoxaluria, Primary
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Diseases
- Lymphoma
- Multiple Myeloma
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Urologic Diseases
Recent trials (24)
- NCT05146882Lead sponsorPhase 2Dec 7, 2021
- NCT05146882Study directorPhase 2Dec 7, 2021
- NCT05001269Study chairPhase 2Oct 31, 2021
- NCT05001269Lead sponsorPhase 2Oct 31, 2021
- NCT05021640Lead sponsorPhase 1Sep 21, 2021
- NCT05021640Study directorPhase 1Sep 21, 2021
- NCT04764448Study directorPhase 2Feb 12, 2021
- NCT04764448Lead sponsorPhase 2Feb 12, 2021
- NCT04580420Study chairPhase 2Oct 31, 2020
- NCT04580420Lead sponsorPhase 2Oct 31, 2020
- NCT04555486Lead sponsorPhase 1Sep 30, 2020
- NCT04555486Study directorPhase 1Sep 30, 2020
- NCT04174118Study directorPhase 1/Phase 2Oct 24, 2019
- NCT04174118Lead sponsorPhase 1/Phase 2Oct 24, 2019
- NCT04042402Lead sponsorPhase 3Jul 9, 2019
Details
- Founded
- Watertown, MA, US Jun 1, 2007
- Last known activity
- Dec 7, 2021